Nivolumab Biosimilar – Research Grade: APC
Receptor tyrosine-protein kinase erbB-2, MLN 19, HER2, HER2/neu
Detects human ErbB2. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Nivolumab. Our Nivolumab biosimilar is for research use only (RUO).
Nivolumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Nivolumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary).
This Allophycocyanin (APC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
This Allophycocyanin (APC) conjugate is stable when stored at 2-8°C. Do not freeze.
Flow Cytometry, IHC
Red Laser (650 nm). Each investigator should determine their own optimal working dilution for specific applications.
ichorbio’s Nivolumab biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
There are no reviews yet.